期刊文献+

乳腺癌中CyclinD1、p21^(ras)、p53、nm23、ER、PR的表达及其与临床病理相关性研究 被引量:2

暂未订购
导出
摘要 目的 探讨乳腺癌中p5 3、p2 1ras、CyclinD1、nm2 3基因蛋白和PR、ER受体的表达与乳腺癌组织学分级、分型、不同年龄、肿瘤体积及有无淋巴结转移的关系。方法 以p5 3、p2 1ras、CyclinD1、nm2 3、PR、ER单抗对 5 6例乳腺癌和 2 1例乳腺良性病变进行标记。结果 p5 3阳性表达在有淋巴结转移组高达 82 .4% ,p5 3、p2 1ras、nm2 3在乳腺癌中的阳性表达分别为 78.6%、69.6%及 48.2 % ,与良性病变组的阳性表达有显著性差异。PR、ER的阳性表达与组织学分级相关 ,有显著性差异。结论 p5 3、ER。
出处 《徐州医学院学报》 CAS 2003年第1期45-47,共3页 Acta Academiae Medicinae Xuzhou
  • 相关文献

参考文献8

二级参考文献8

  • 1Barnes DM, Dublin EA, Fisher CJ, et al. Immunohistochemieal detection of p53 protein in mammary carcinoma: an important new independent indicator of prognosis, Hum Pathool 1993,24:469-476..
  • 2Matsushime H, Roussel NF, Ashman RA, et al,Colony-stimulating factor 1 regulates novel cyclin during the G1 phase of the cell cycle, Cell, 1991,65:701-713.
  • 3Gillett C, Fantle V, Smith R, et al. Amplification and overexpression of cyclinD1 in breast cancer detected by immunohistochemical staining. Cancer Res, 1994,54:1812-1817.
  • 4Bartkova J, Luks J, Muller H, et al. cyclinD1 protein expression and function in human breast cancer. Int J Cancer,1994,57:353.
  • 5Mate JL. Ariza A. Aracil C.et al. cyclinD1 overexpression in non small cell lung carcinoma:correlation with ki67 labelling index and poor cytoplasmic differentiation. J Pathol,1996,180:395-399..
  • 6Robert A, Weiberg.The retinoblastoma protein and cell cycle control Cell,1995,81:323-330.
  • 7Jonathan M, Horowitz, park SH, et al.Frequent inactivation of the retinoblastoma anti-oncogene is restricted to a subset of human tumor cells.Proc Natl Acad Sci USA,1990,87:2775-2779.
  • 8Masakuni Noguchi,Hirohisa Kitagawa,Kazuo Kinoshita,Michael Thomas,Itsuo Miyazaki,Yashuo Saito,Yuji Mizukami,Akitaka Nonomura,Takatoshi Michigishi,Shinobu Nakamura. The relationship of p53 Protein and lymph node metastases in invasive breast cancer[J] 1994,Surgery Today(6):512~517

共引文献32

同被引文献22

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部